Central venous access device (CVAD) insertion (ports)
You may need to have a surgical procedure to insert or remove a central venous access
device (CVAD). A venous access device is often implanted in the upper chest or the
arm. Examples include a single lumen Hickman® catheter
or a Port-a-Cath (also called a line or a port). This
allows easy access to a vein for the many injections needed to manage
hemophilia.
These procedures are common for people with inhibitors.
However, they are still surgeries. Bleed control before,
during, and after surgery is important.
The port is a small metal or plastic reservoir with
a rubber diaphragm. This is connected to a catheter.
The whole device is surgically implanted under the skin. The catheter is then threaded
into a large vein in the chest or arm. Injections are given by inserting a special
needle through the skin and into the rubber diaphragm. The fluid then flows through
the catheter into the vein.
Risks and benefits of ports
A port makes giving frequent injections easier. It eliminates the problem of finding
a vein. However, there are risks, including infection or blood
clots. Infections occur in about half of people using a port after about
5 years. The rate of infection is higher in people with an inhibitor. The risk of
infection also increases with the length of time the port remains in place. It is
recommended that the port be used for a few years at most. Using careful sterile
techniques for injections may reduce the chance of infection. It helps if your doctor
monitors the device. You and your doctor should weigh the risks and benefits of
using a port.
Adequate blood clotting therapy is essential during
implantation or removal of a port. For people with inhibitors, this usually means
a bypassing agent.
Learn more
Next: Dental procedures>
Novo Nordisk
Inc., 100 College Road West, Princeton, New Jersey 08540 U.S.A.
Changing Possibilities in Hemophilia
® is
a registered trademark owned by Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
®
© 2011 Novo Nordisk
0411-00002484-1 November 2011
®
SITE MAPPRIVACY POLICYSHARE YOUR DREAM